AIHTA - Publications - Search - [Erbitux®/Cetuximab for metastatic colorectal cancer]

Wild, C. (2005): [Erbitux®/Cetuximab for metastatic colorectal cancer]. HTA-Newsletter 40: pp. 2-3.

[thumbnail of HTA-Newsletter 40]
PDF (HTA-Newsletter 40) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Official URL:

Item Type:HTA Newsletter Item
Keywords:Erbitux, cetuximab, monoclonal antibody, metastatic colorectal cancer, second-line treatment, combination therapy
Subjects:WI Digestive system > WI 400-560 Intestines
QW Microbiology. Immunology
WB Practice of medicine > WB 340-356 Drug Administration
Related URLs:
References:1. London Cancer Drugs 2005: Cetuximab. URL:

2. EMEA 2004: Cetuximab. URL:

3. HAYES Alert 2004: Erbitux approved by FDA to treat subset of patients with colorectal cancer.

4. NHSC/GB 2002: Cetuximab for head and neck and colorectal cancer – horizon scanning review. URL:
Deposited on:25 Feb 2008 19:07
Last Modified:15 Jul 2020 17:36

Repository Staff Only: item control page